'Tax pharma companies if they fail to act on AMR', says Review chief Lord O'Neill

Vet Rec. 2018 Jun 30;182(26):728. doi: 10.1136/vr.k2835.
No abstract available

Publication types

  • News

MeSH terms

  • Animals
  • Anti-Bacterial Agents / therapeutic use
  • Antimicrobial Stewardship
  • Drug Discovery
  • Drug Industry* / economics
  • Drug Resistance, Bacterial*
  • Humans
  • Taxes*
  • United Kingdom

Substances

  • Anti-Bacterial Agents